These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1844700)

  • 21. [Chemotherapy in colorectal carcinoma. From "one-drug-show" to therapeutic multiplicity].
    Köster W; Stahl M; Wilke H
    MMW Fortschr Med; 2000 Aug; 142(31-32):30-2. PubMed ID: 10992764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination chemotherapy--present status and problems].
    Furue H
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):589-96. PubMed ID: 10234287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens.
    Simon R; Norton L
    Nat Clin Pract Oncol; 2006 Aug; 3(8):406-7. PubMed ID: 16894366
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S; Schwartz EL
    Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of carboplatin in the treatment of lung cancer].
    Bréchot JM
    Bull Cancer; 2000 Aug; 87 Spec No():34-9. PubMed ID: 11082721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer therapy with combinations of biological response modifiers and cytotoxics: an update.
    Borden EC; Creekmore SP
    Cancer Cells; 1990 Jul; 2(7):217-20. PubMed ID: 2204387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
    Sevelda P; Kurz C; Obermair A; Vavra N; Breitenecker G; Czerwenka K; Dittrich C; Salzer H
    Wien Klin Wochenschr; 1993; 105(24):732-6. PubMed ID: 8116312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing chemotherapy intensity in aggressive lymphomas: a renewal?
    Coiffier B
    J Clin Oncol; 2003 Jul; 21(13):2457-9. PubMed ID: 12829662
    [No Abstract]   [Full Text] [Related]  

  • 31. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer.
    Rose PG
    Oncologist; 2005 Mar; 10(3):205-14. PubMed ID: 15793224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methodology and limitations of pre-clinical models for the development of anticarcinogenic chemotherapy combinations].
    Vassal G
    Bull Cancer; 1998 Nov; 85(11):929-34. PubMed ID: 9951420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy of brain tumors in childhood. Review of the literature and pilot protocol].
    Kühl J
    Klin Padiatr; 1988; 200(3):214-20. PubMed ID: 3062258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
    Kerbel RS
    Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA; Looney WB; Carter WH; Reto DC; Campbell ED
    In Vivo; 1994; 8(1):107-12. PubMed ID: 8054501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic therapy for metastatic colorectal cancer: current options, current evidence.
    Kelly H; Goldberg RM
    J Clin Oncol; 2005 Jul; 23(20):4553-60. PubMed ID: 16002847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internet-based system for anti-tumor chemotherapy evaluation.
    Klimes D; Kubasek M; Smid R; Dusek L
    Comput Methods Programs Biomed; 2009 Mar; 93(3):292-6. PubMed ID: 19084288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose cisplatin carboplatin chemotherapy in primary advanced epithelial ovarian cancer.
    Fanning J; Hilgers RD
    Gynecol Oncol; 1993 Nov; 51(2):182-6. PubMed ID: 8276291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.